Please login to the form below
Purdue Pharma appoints Dr Craig Landau as its CEO
He also takes up president role
Purdue Pharma has appointed Dr Craig Landau as its new chief executive officer and president, roles that will see him be responsible for the firm’s US operations and retain responsibility for Purdue’s Canadian operations.
Landau first joined the Connecticut, US-based firm as president and CEO of Purdue Pharma Canada, he's spent the last three years diversifying and stabilising the business through a number of strategic business development deals.
He said: "I am honoured to be leading these organisations at such an exciting time.
"I look forward to building on Purdue’s rich history and working with my talented colleagues as we continue to broaden our portfolio and innovate to support healthcare professionals and serve patient needs.”
He succeeds Mark Timey who leaves Purdue Pharma to “pursue other career opportunities”.
COVID-19 Updates and Daily News
Featured jobs
-
SENIOR MEDICAL WRITER
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
- Inovio plans late-stage COVID-19 vaccine study in second quarter 2021
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- AZ/Oxford University vaccine shows 82.4% efficacy with extended dosing schedule
- AZ refutes reports suggesting its COVID-19 vaccine is less effective in the elderly
- Novavax to provide 1.1 billon COVID-19 vaccine doses to COVAX
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- The Good Ideas Group - Showreel
- J&J submits one-dose COVID-19 vaccine to WHO for emergency use listing
- FDA fast-tracks review of Incyte’s Jakafi for chronic GVHD
- Sanofi, Regeneron’s Libtayo scores first-line NSCLC approval in the US
- bluebird bio posts modest Q4 revenue growth as it continues investigation into troubled LentiGlobin
- WHO agrees to no-fault compensation for rare serious side effects from COVAX-distributed vaccines
PMHub
3 Monkeys Zeno
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...
Latest intelligence
- Reaching patients and HCPs during the pandemic
- COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
- #DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
- Take a look at this infographic showing some of the most notorious clinical trials and medical research in history....
- Looking back at the year when everything changed
- COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families....
Quick links
Infographics
